FOR IMMEDIATE RELEASE    

Merial Announces Introduction of EQUIOXX¨ (firocoxib) Injection – Continuing the New Movement in Equine Osteoarthritis Pain Management

Duluth, GA. – September 28, 2010 – With a long-standing commitment to providing veterinarians the highest quality, most relevant products, Merial is pleased to introduce another movement in equine pain management – EQUIOXX¨ (firocoxib) Injection, which is labeled to control joint pain and inflammation associated with equine osteoarthritis (OA), also known as degenerative joint disease (DJD).1

When it comes to treating horses with pain and inflammation, 2010 survey results show more than 90 percent of veterinarians think it is “extremely important” or “very important” to have multiple formulations of equine nonsteroidal anti-inflammatory drugs (NSAIDs) available. A large majority consider it “extremely important” to have an oral paste (81 percent) available while 82 percent believe it is “extremely important” to have an injectable formulation available